Management of Biloma
The management of biloma requires immediate source control through percutaneous drainage for symptomatic or infected collections, combined with broad-spectrum antibiotics and endoscopic biliary intervention to address the underlying bile leak. 1
Initial Diagnostic Workup
When biloma is suspected (particularly after hepatobiliary procedures, trauma, or in transplant recipients), obtain:
- Abdominal triphasic CT as first-line imaging to detect fluid collections and ductal dilation 1, 2
- CE-MRCP for complete morphological evaluation of the biliary tree and to identify the leak source 1, 2
- Liver function tests and inflammatory markers to assess severity and guide monitoring 1
Treatment Algorithm
Step 1: Source Control (First Priority)
Percutaneous drainage is the treatment of choice for symptomatic or infected bilomas 1, 2:
- Perform US or CT-guided catheter drainage for all symptomatic collections 1
- For large cholangiolytic abscesses not responding to antibiotics within 48-72 hours, proceed immediately to percutaneous needle aspiration or catheter drainage 1
- Most traumatic bilomas regress spontaneously, but any symptomatic or infected collection requires intervention 2
Step 2: Antibiotic Therapy
Start broad-spectrum antibiotics immediately for infected bilomas or biliary peritonitis 1:
- Recommended regimens: piperacillin/tazobactam, imipenem/cilastatin, or meropenem 1, 3
- Standard duration: 5-7 days for biloma and generalized peritonitis after successful drainage 1, 3
- Extended duration (2 weeks) if Enterococcus or Streptococcus is isolated to prevent infectious endocarditis 1, 3
- Continue parenteral antibiotics for 48-72 hours initially with biliary drainage; if no response, extend to 7-10 days after percutaneous drainage 3
Step 3: Biliary Drainage and Leak Management
Address the underlying bile leak through endoscopic intervention 1, 2:
- ERCP with sphincterotomy is the preferred initial procedure for both diagnosis and treatment 4, 5
- Place biliary stent across the leak site to divert bile flow and promote healing 1, 2, 5
- For recurrent or uncontrolled cholangitis, establish biliary drainage via PTBD or ERCP with stent placement 1
- Remove any retained bile duct stones identified during ERCP 5
Critical pitfall: Failure to perform sphincterotomy in suppurative cholangitis can contribute to bile backflow and worse outcomes 6
Step 4: Complex or Refractory Cases
For bilomas not responding to standard treatment:
- EUS-guided transmural drainage achieves 75% clinical success in complex cases with altered anatomy or conventional treatment failure 7
- Transpapillary/transfistulary drainage with double-pigtail stent placement achieves 67% clinical success 7
- These advanced endoscopic techniques may obviate the need for additional surgery in most patients 7
Step 5: Surgical Intervention
Reserve surgery for:
- Biliary peritonitis requiring source control beyond percutaneous drainage 1
- Major ductal injuries not amenable to endoscopic management 5
- Severe complicated intra-abdominal sepsis with organ failure and gross contamination (consider open abdomen therapy) 1
Special Populations
Liver Transplant Recipients
- Biloma incidence is 10-25% in transplant recipients 2
- Percutaneous or endoscopic stenting of biliary strictures plus biloma drainage may restore normal function 1
- Consider vascular complications; may require stenting or anastomotic revision 1
External Biliary Fistula
- If no intraperitoneal collection exists and infectious signs are absent, antimicrobial therapy may not be necessary 1
Monitoring and Follow-up
- Serial imaging and laboratory tests to monitor treatment response 1
- Regular evaluation of drainage catheters for appropriate removal timing 1
- Monitor for complications including hepatic abscess, biliary peritonitis, and sepsis 2
Common Pitfalls to Avoid
- Do not delay biliary decompression beyond 48 hours in moderate-to-severe cases while continuing antibiotics alone—source control is paramount 3
- Do not continue antibiotics indefinitely for residual anatomical problems; address with repeat intervention 3
- Adjust therapy based on bile and blood culture results once available 3